That was a great earnings report and even better with the data on the pending approval.

Management definitely has addressed the negatives to make sure the launch is as flawless as possible. The fact that they have some 60 sales rep signed on contingent contracts speaks to the intent to hit the streets running.

And for all the noise that the FDA will approve it subject to training the doctors is so stupid as the Company has taken leadership on this issue as it will not allow a doctor to prescribe it unless s/he have taken the training.

With Pfizer moving up its application in Europe this, too, speaks to the positive upside, plus, the feedback from doctors that there is pent up demand.

I have never been more optimistic about the launch and would encourage everyone to read the transcript to get up to speed.